Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85.5K Buy
1,100
+600
+120% +$67.9K ﹤0.01% 418
2026
Q1
$40.6K Hold
500
﹤0.01% 449
2025
Q4
$54.7K Buy
+500
New +$54.6K ﹤0.01% 435

Other funds holding ABVX

Union Bancaire Privee's ABVX Position: Q2 2026 in Review

Union Bancaire Privee increased its Abivax (ABVX) stake by 120% in Q2 2026, buying an estimated $67.9K and bringing the position to 1,100 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #418.

Union Bancaire Privee first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 20 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Union Bancaire Privee held 1,100 shares of Abivax worth $85.5K as of Q2 2026.
  • Union Bancaire Privee bought 600 Abivax shares in Q2 2026, an estimated $67.9K.
  • Abivax made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #418 holding.
  • Union Bancaire Privee first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
  • 20 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.